Piramal Pharma (NSE:PPLPHARMA) Ending Cash Position : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Ending Cash Position?

Piramal Pharma's Ending Cash Position for the quarter that ended in Mar. 2025 was ₹0 Mil.

Piramal Pharma's annual Ending Cash Position increased from Mar. 2023 (₹532 Mil) to Mar. 2024 (₹2,192 Mil) but then declined from Mar. 2024 (₹2,192 Mil) to Mar. 2025 (₹1,823 Mil).

Piramal Pharma Ending Cash Position Historical Data

The historical data trend for Piramal Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Ending Cash Position Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Ending Cash Position

851.80

532.30

2,191.90

1,823.20

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial											-	-	-	-	-

Piramal Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Piramal Pharma's Ending Cash Position for the fiscal year that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2191.9	+	-368.7
	=	1,823

Piramal Pharma's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Piramal Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Ending Cash Position

Traded in Other Exchanges

543635:India

Address

Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramalpharma.com

Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines